publicFDA · USA · Updated Sep 4, 2026Translated From Spanish
Temporary Policies for Compounding Certain Starter Parenteral Nutrition Drug Products for Neonates Guidance for Industry September 2026
Regulatory Affairs must implement the new compounding policies immediately to ensure compliance and mitigate risks associated with product availability.
Country ComplianceRegulatory Intelligence Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward